The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms

A compelling body of non-randomized evidence has established stereotactic ablative lung radiotherapy (SABR) as a standard of care for medically inoperable patients with peripheral early-stage non-small cell lung cancer (NSCLC). This convenient outpatient therapy, which is typically delivered in 3-8...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahele, Max, Senan, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138920/
https://www.ncbi.nlm.nih.gov/pubmed/21811422
http://dx.doi.org/10.4143/crt.2011.43.2.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138920/
https://www.ncbi.nlm.nih.gov/pubmed/21811422
http://dx.doi.org/10.4143/crt.2011.43.2.75

Ejemplares similares